![Fred Grossman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fred Grossman
President at
COYA THERAPEUTICS, INC.
Net worth: 13 062 $ as of 2026-05-30
Profile
Dr. Fred Grossman is a President & Chief Medical Officer at Coya Therapeutics, Inc. Dr. Grossman was previously employed as a Chief Medical Officer by Empyrean Neuroscience, Inc., a Chief Medical Officer by Mesoblast Ltd., a Chief Medical Officer by Mesoblast, Inc., a President & Chief Medical Officer by Glenmark Pharmaceuticals Ltd., a President & Chief Medical Officer by Glenmark Pharmaceuticals Inc., USA, a Head-Clinical Development & Medical Affairs by Sunovion Pharmaceuticals, Inc., and a Global Head-Medical Affairs Organization by Bristol Myers Squibb Co. He also served on the board at Reunion Neuroscience, Inc. He received his undergraduate degree from Hahnemann University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-30 | 2,710 ( 0.01% ) | 13 062 $ | 2026-05-30 |
Fred Grossman active positions
| Companies | Position | Start |
|---|---|---|
| COYA THERAPEUTICS, INC. | President | 2023-07-16 |
Former positions of Fred Grossman
| Companies | Position | End |
|---|---|---|
Empyrean Neuroscience, Inc.
 Empyrean Neuroscience, Inc. Pharmaceuticals: OtherHealth Technology Engages in genetic engineering of fungi and plants to create neuroactive therapeutics | Chief Tech/Sci/R&D Officer | 2022-12-31 |
| MESOBLAST LIMITED | Chief Tech/Sci/R&D Officer | 2022-02-01 |
| GLENMARK PHARMACEUTICALS LIMITED | President | 2018-12-31 |
Glenmark Pharmaceuticals Inc., USA
 Glenmark Pharmaceuticals Inc., USA Pharmaceuticals: MajorHealth Technology Manufactures and distributes generic pharmaceutical products | President | 2018-07-31 |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Corporate Officer/Principal | 2015-09-30 |
Training of Fred Grossman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
79
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Health Technology |
Mesoblast, Inc.
 Mesoblast, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes biopharmaceutical products | Health Technology |
Glenmark Pharmaceuticals Ltd.
 Glenmark Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals | Health Technology |
Mesoblast Ltd.
 Mesoblast Ltd. BiotechnologyHealth Technology Engages in the development and commercialization of biological and adult stem cells products | Health Technology |
Hahnemann University
 Hahnemann University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Glenmark Pharmaceuticals Inc., USA
Glenmark Pharmaceuticals Inc., USA Pharmaceuticals: MajorHealth Technology Manufactures and distributes generic pharmaceutical products | Health Technology |
Coya Therapeutics, Inc.
 Coya Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that focuses on research and development of therapies to enhance the function of regulatory T cells | Health Technology |
Empyrean Neuroscience, Inc.
Empyrean Neuroscience, Inc. Pharmaceuticals: OtherHealth Technology Engages in genetic engineering of fungi and plants to create neuroactive therapeutics | Health Technology |
Reunion Neuroscience, Inc.
 Reunion Neuroscience, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops FDA-approved serotonergic psychedelic therapeutic solutions for underserved mental health disorders | Health Technology |
- Stock Market
- Insiders
- Fred Grossman
